The Experience of Surfactant Therapy in Severe COVID-19 Pneumonia: A Case Report
Keyword(s):
The COVID-19 pandemic has presented challenges to finding effective treatment for lung damage. Medical researchers from different countries recognize the deficiency of pulmonary surfactant (PS) as a significant cause of the alveolar collapse, followed by microatelectasis and severe disturbances in the ventilation-perfusion relationship. Due to the pathophysiological rationale, experimental confirmations, and accumulated clinical experience, the PS preparations can be used to treat patients with severe COVID-19. The article provides a description of a case when ST was successfully used in a patient with severe COVID-19 pneumonia.
2017 ◽
Vol 98
(2)
◽
pp. E42
Keyword(s):
2014 ◽
Vol 28
(2)
◽
pp. 122-129
◽
Keyword(s):
Keyword(s):
Keyword(s):
Keyword(s):